Follow
Mirko Minini
Mirko Minini
post-doc, CRSA - INSERM, Paris
Verified email at inserm.fr
Title
Cited by
Cited by
Year
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
N Pernigoni, E Zagato, A Calcinotto, M Troiani, RP Mestre, B Calė, ...
Science 374 (6564), 216-224, 2021
1952021
Nutritional and acquired deficiencies in inositol bioavailability. Correlations with metabolic disorders
S Dinicola, M Minini, V Unfer, R Verna, A Cucina, M Bizzarri
International journal of molecular sciences 18 (10), 2187, 2017
1172017
From implantation to birth: insight into molecular melatonin functions
G Carlomagno, M Minini, M Tilotta, V Unfer
International journal of molecular sciences 19 (9), 2802, 2018
902018
Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement
S Dinicola, G Fabrizi, MG Masiello, S Proietti, A Palombo, M Minini, ...
Experimental cell research 345 (1), 37-50, 2016
742016
Melatonin, mitochondria, and the cancer cell
S Proietti, A Cucina, M Minini, M Bizzarri
Cellular and molecular life sciences 74, 4015-4025, 2017
692017
Increase in motility and invasiveness of MCF 7 cancer cells induced by nicotine is abolished by melatonin through inhibition of ERK phosphorylation
S Proietti, A Catizone, MG Masiello, S Dinicola, G Fabrizi, M Minini, ...
Journal of pineal research 64 (4), e12467, 2018
392018
Active fraction from embryo fish extracts induces reversion of the malignant invasive phenotype in breast cancer through down-regulation of TCTP and modulation of E-cadherin/β …
S Proietti, A Cucina, A Pensotti, PM Biava, M Minini, N Monti, A Catizone, ...
International journal of molecular sciences 20 (9), 2151, 2019
332019
Constraints shape cell function and morphology by canalizing the developmental path along the Waddington's landscape
M Bizzarri, A Giuliani, M Minini, N Monti, A Cucina
Bioessays 42 (4), 1900108, 2020
212020
The Key Role of IP6K: A Novel Target for Anticancer Treatments?
M Minini, A Senni, V Unfer, M Bizzarri
Molecules 25 (19), 4401, 2020
172020
miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting
M Minini, A Senni, X He, S Proietti, D Liguoro, A Catizone, A Giuliani, ...
Cancer Letters 520, 48-56, 2021
132021
Redifferentiation therapeutic strategies in cancer
M Bizzarri, A Giuliani, A Cucina, M Minini
Drug Discovery Today 25 (4), 731-738, 2020
132020
Cancer-associated fibroblasts and extracellular matrix: therapeutical strategies for modulating the cholangiocarcinoma microenvironment
M Minini, L Fouassier
Current Oncology 30 (4), 4185-4196, 2023
102023
Field-dependent effects in biological systems
M Bizzarri, N Monti, M Minini, A Pensotti
Organisms. Journal of Biological Sciences, 35-42, 2019
82019
Reduced burden of chemotherapy side-effects in patients receiving inositol hexakisphosphate alone or in association with myo-inositol
R Verna, A Guiliani, V Todde, M Minini, V Unfer
Cancer Stud. Ther 3, 1-5, 2018
72018
Revisiting the Concept of Human Disease: Rethinking the Causality Concept in Pathogenesis for Establishing a Different Pharmacological Strategy
M Bizzarri, M Minini, N Monti
Approaching Complex Diseases: Network-Based Pharmacology and Systems …, 2020
42020
Metformin in obstetrics and gynecology–Evaluation of its activity and possible risks
G Monastra, M Minini
IJMDAT 3, e258, 2020
32020
A double-edge sword: The role of D-chiro-inositol in oocyte and embryo quality
M Minini, G Monastra, S Dinicola
Int. J. Med. Dev. Adjust. Treat 2, e208, 2019
32019
Approaching Complex Diseases
M Bizzarri, M Minini, N Monti
Springer Nature, 1-34, 2020
22020
Experimental Model of Biliary Tract Cancers: Subcutaneous Xenograft of Human Cell Lines in Immunodeficient Nude Mice
B Lekbaby, J Vaquero, A Pavy, M Minini, E Gonzalez-Sanchez, J Augustin, ...
Liver Carcinogenesis: Methods and Protocols, 87-98, 2024
2024
Crosstalk between cancer cell plasticity and immune microenvironment in cholangiocarcinoma
M Minini, A Pavy, B Lekbaby, L Fouassier
2024
The system can't perform the operation now. Try again later.
Articles 1–20